usa_2_0147|AXGT|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
usa_2_0147|AXGT|1|Axovant Gene Therapies Ltd Total Current Assets (Quarterly) (USD)|Axovant Gene Therapies Ltd Cash and Short Term Investments (Quarterly) (USD)|Axovant Gene Therapies Ltd Inventories (Quarterly) (USD)|Axovant Gene Therapies Ltd Net PP&E (Quarterly) (USD)|Axovant Gene Therapies Ltd Goodwill and Intangibles (Quarterly) (USD)|Axovant Gene Therapies Ltd Total Liabilities (Quarterly) (USD)|Axovant Gene Therapies Ltd Total Current Liabilities (Quarterly) (USD)|Axovant Gene Therapies Ltd Total Long Term Liabilities (Quarterly) (USD)|Axovant Gene Therapies Ltd Total Deposits (Quarterly) (USD)|Axovant Gene Therapies Ltd Book Value (Quarterly) (USD)|Axovant Gene Therapies Ltd Retained Earnings (Quarterly) (USD)|Axovant Gene Therapies Ltd Treasury Stock (Quarterly) (USD)|Axovant Gene Therapies Ltd EV to Revenues|Axovant Gene Therapies Ltd EV to Earnings|Axovant Gene Therapies Ltd EV to Free Cash Flow|Axovant Gene Therapies Ltd EV to Assets (Quarterly)|Axovant Gene Therapies Ltd PS Ratio|Axovant Gene Therapies Ltd PE Ratio|Axovant Gene Therapies Ltd Price to Book Value|Axovant Gene Therapies Ltd PEG Ratio|Axovant Gene Therapies Ltd Debt to Equity Ratio|Axovant Gene Therapies Ltd Dividend Yield|Axovant Gene Therapies Ltd Shareholder Yield (TTM)|Axovant Gene Therapies Ltd Percent of Shares Outstanding Short|Axovant Gene Therapies Ltd Total Receivables (Quarterly) (USD)|Axovant Gene Therapies Ltd Total Payables (Quarterly) (USD)|Axovant Gene Therapies Ltd Total Capital Stock (Quarterly) (USD)|Axovant Gene Therapies Ltd Return on Invested Capital|Axovant Gene Therapies Ltd Quality Ratio Score|Axovant Gene Therapies Ltd Momentum Score|Axovant Gene Therapies Ltd Beta (1Y)|Axovant Gene Therapies Ltd Sustainable Growth Rate (TTM)|Axovant Gene Therapies Ltd Institutional Investor Ownership Percentage|Axovant Gene Therapies Ltd Average Diluted Shares Outstanding (Quarterly)|Axovant Gene Therapies Ltd Total Employees (Annual)|Axovant Gene Therapies Ltd EPS Diluted (Quarterly) (USD)|Axovant Gene Therapies Ltd Shares Outstanding|Axovant Gene Therapies Ltd Repurchase of Capital Stock (Quarterly) (USD)|Axovant Gene Therapies Ltd Ordinary Shares Number (Quarterly)|Axovant Gene Therapies Ltd Payout Ratio|Axovant Gene Therapies Ltd Quick Ratio (Quarterly)|Axovant Gene Therapies Ltd Normalized Diluted EPS (Quarterly) (USD)|Axovant Gene Therapies Ltd Stock Buybacks (Quarterly) (USD)|Axovant Gene Therapies Ltd Effective Tax Rate (TTM)|Axovant Gene Therapies Ltd Return on Equity|Axovant Gene Therapies Ltd Net Income (TTM) (USD)|Axovant Gene Therapies Ltd Revenue (TTM) (USD)|Axovant Gene Therapies Ltd Dividend Per Share (Quarterly) (USD)|Axovant Gene Therapies Ltd Revenue (Quarterly) (USD)|Axovant Gene Therapies Ltd Gross Profit (Quarterly) (USD)|Axovant Gene Therapies Ltd SG&A Expense (Quarterly) (USD)|Axovant Gene Therapies Ltd Pre-Tax Income (Quarterly) (USD)|Axovant Gene Therapies Ltd Net Income (Quarterly) (USD)|Axovant Gene Therapies Ltd Net Interest Income (Quarterly) (USD)|Axovant Gene Therapies Ltd Price (USD)|Axovant Gene Therapies Ltd Total Return Price (USD)|Axovant Gene Therapies Ltd Enterprise Value (USD)|Axovant Gene Therapies Ltd 30-Day Average Daily Volume|Axovant Gene Therapies Ltd 1 Year Price Returns (Daily)||
usa_2_0147|AXGT|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
usa_2_0147|AXGT|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|daily|monthly|daily||
usa_2_0147|AXGT|5|91.35|91.35|0|91.35|0|91.35|91.35|91.35|0|91.35|91.35|0|0|0|6.97489539749|0|0|0|6.98561151079|0|0|1.44937176644|0|15.2301587302|91.2941176471|91.35|91.35|0|0|31.0612244898|30.4509803922|0|32.7142857143|91.35|203|91.35|29.9692307692|0|91.35|0|0|91.35|91.35|91.2941176471|0|91.2941176471|0|0|0|0|91.35|91.35|91.35|91.3125|7.00357142857|7.00357142857|6.98561151079|7.00364963504|6.95633187773||
usa_2_0147|AXGT|6|20|20|0|20|0|20|20|20|0|20|20|0|0|0|239|0|0|0|278|0|0|1353|0|126|17|20|20|0|0|49|51|0|14|20|9|20|65|0|20|0|0|20|20|17|0|17|0|0|0|0|20|20|20|16|280|280|278|274|229||
usa_2_0147|AXGT|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
usa_2_0147|AXGT|201503|||||||||||||||||||||||||||||||||||8||||||||||||||||||||||||||
usa_2_0147|AXGT|201506|331.096|331.069||0.016||9.569|4.569|5||321.725|-49.105||||||||6.2808|||0||2.4256||2.637|0.001|||||||10.0385|11|-2.48|12.3938||12.3938|||-2.48|-336.893||||||||15.393|-24.879|-24.953||157.2|157.2|1689.6162|770961.6||116.8|99.84
usa_2_0147|AXGT|201509|322.515|320.211||0.033||10.378|10.378|0||312.285|-61.166||||||||3.7722|||0||4.9229||3.439|0.001|||||||12.3938|18|-1.2|12.3938||12.3938|||-1.2|0||||||||5.743|-15.142|-15.166||122.64|122.64|882.5319|476959.5667||100.24|138.24
usa_2_0147|AXGT|201512|303.817|299.998||0.061||15.892|15.892|0||287.986|-124.521||||||||6.1436|||0||4.8085||5.494|0.001|||||||12.3938||-5.12|12.3938||12.3938|||-5.12|0||||||||28.23|-62.554|-63.356||152.48|152.48|1598.3492|310040.4667||136.88|97.84
usa_2_0147|AXGT|201603|282.086|276.251||0.089||15.755|15.755|0||266.743|-154.192||||-14.6865||||3.9387|||0||5.5779|0.97|2.436|0.001|||||||12.3895|36|-2.4|12.3938||12.3938|||-2.4|0|0.0135||-133.146|||||7.154|-30.589|-29.671||91.52|91.52|834.2826|295523.1667||109.76|105.68
usa_2_0147|AXGT|201606|256.753|252.657||0.106||16.933|16.933|0||240.249|-192.247||||-14.0276||||4.6315|||0||6.5563|0.796|5.061|0.001|||3|-0.0276|||12.3938||-3.04|12.3938||12.3938|||-3.04|0|-0.0383||-146.248|||||12.631|-37.907|-38.055|0|99.68|99.68|959.163|453256.7|-41.1191|113.28|133.12
usa_2_0147|AXGT|201609|234.444|229.664||0.103||28.643|28.643|0||205.944|-234.499||||-16.0197||||6.022|||0||9.6182|0.675|12.216|0.001|||9|0.0511|||12.3951||-3.44|12.3952||12.3952|||-3.44|0|-0.441||-173.334|||||9.449|-41.523|-42.252|0|116.72|116.72|1194.1107|677856.4|-0.6807|109.52|109.6
usa_2_0147|AXGT|201612|205.577|200.405||0.159||39.595|39.595|0||166.464|-282.31||||-11.7107||||5.9802|||0||4.4146|0.938|14.198|0.001|||2|1.3924|||12.3952||-3.84|12.3952||12.3952|||-3.84|0|0.1279||-157.789|||||11.342|-47.972|-47.811|0|99.36|99.36|1001.9231|260568.5|-35.0418|98|101.68
usa_2_0147|AXGT|201703|219.688|212.573||0.142||97.702|46.266|51.436||124.837|-335.143||||-11.7666||||8.7507|||0||5.1838|0.658|11.47|0.001|||3|2.1635|||12.3953|69|-4.24|12.3955||12.3955|||-4.24|0|0.5824||-180.951|||||12.299|-54.609|-52.833|-1.143|117.52|117.52|1256.2789|397865.3667|29.4273|184.72|167.04
usa_2_0147|AXGT|201706|306.709|297.858||2.294||102.806|51.054|51.752||206.197|-404.644||||-20.0112||||19.2785|||0||3.5513|1.224|13.013|0.001|||9|1.6324|||13.3001||-5.2|13.4342||13.4342|||-5.2|-134.628|-0.6218||-212.162|||||21.518|-66.747|-69.266|-1.874|179.28|179.28|2245.5356|529101.2|83.372|175.76|157.92
usa_2_0147|AXGT|201709|242.773|235.373||3.367||92.964|40.896|52.068||153.176|-473.73||||-3.5175||||3.6451|||0||5.0969|2.813|7.102|0.001|||7|-0.5925|||13.4492|89|-5.12|13.4638||13.4638|||-5.12|0.113|0.42||-238.996|||||30.112|-70.676|-69.086|-1.878|55.92|55.92|505.4979|2520453.0333|-51.9573|43.44|42.4
usa_2_0147|AXGT|201712|193.136|188.251||3.232||89.72|42.141|47.579||106.648|-531.632||||-2.1084||||3.7269|||0||2.9413|2.79|2.392|0.001|||1|-5.595|||13.4649|80|-4.32|13.4735||13.4735|||-4.32|0|0.3293||-249.087|||||18.032|-57.878|-57.902|-1.95|42.4|42.4|387.5601|984395.3333|-57.224|16.24|11.52
usa_2_0147|AXGT|201803|158.262|154.337||2.524||89.5|46.575|42.925||71.286|-556.951||||-0.0372||||1.3442|||0||2.2544|1.751|4.96|0|||1|-3.031|||13.4725|45|-1.87|13.4735||13.4735|||-1.87|0|-0.4174||-221.573|||||2.244|-25.351|-25.319|-1.843|10.8|10.8|7.5|770100.5667|-90.3051|8.56|11.6
usa_2_0147|AXGT|201806|101.998|92.934||1.802||81.758|43.511|38.247||25.826|-608.839||||-0.7238||||3.4023|||0||3.5984|1.616|3.587|0.001|||1|-1.6245|||13.4737||-3.85|13.4744||13.4744|||-3.85||0.7389||-204.195|||||11.754|-51.81|-51.888|-1.97|18.72|18.72|140.8802|11378195.6|-90.2398|18.48|19.68
usa_2_0147|AXGT|201809|96.351|90.726||1.513||82.309|49|33.309||19.879|-642.674||||-1.1459||||10.6831|||0||3.7015|1.53|4.676|0.001|||1|-0.3428|||15.1079||-2.24|15.2719||15.2719|||-2.24|-25.014|-0.0972||-168.944|||||10.622|-33.741|-33.835|-1.932|18.08|18.08|236.0066|812119.3|-90.3505|16.16|14.48
usa_2_0147|AXGT|201812|91.402|84.939||1.365||73.456|45.205|28.251||22.76|-676.97||||-0.6872||||7.7794|||0||2.906|1.58|1.711|0.002|||1|2.2782|||16.0965||-2.13|19.441||19.441|||-2.13|-31.68|-0.1323||-145.338|||||10.933|-34.244|-34.296|-1.906|7.9592|7.9592|117.2393|998984.2667|-81.7073|8.16|10.4
usa_2_0147|AXGT|201903|114.584|106.999||1.278||66.493|43.499|22.994||56.213|-686.016||||-1.3142||||10.6484|||0||3.9016|1.726|1.698|0|||5|3.5811|||19.7091|57|-0.45|22.7799||22.7799|||-0.45|-37.855|-0.1032||-129.065|||||6.157|-9.137|-9.046|-1.722|10.64|10.64|206.2529|454657|-1.4599|9.12|7.03
usa_2_0147|AXGT|201906|91.749|84.176||3.779||72.093|54.035|18.058||29.352|-714.073||||-0.6156||||2.5895|||0||6.0474|1.916|2.896|0|||4|2.5481||22.4188|22.7801||-1.23|22.7807||22.7807|||-1.23|0|-0.0885||-105.234|||||6.468|-28.019|-28.057|-1.558|6.39|6.39|82.7406|1122103.8|-66.972|7.16|6.38
usa_2_0147|AXGT|201909|66.829|60.255||3.318||59.024|47.279|11.745||17.04|-727.957||||-1.3131||||5.5881|||0||4.0835|2.071|1.567|0|||2|2.395||16.7807|22.7832||-0.61|22.7917||22.7917|||-0.61|0|-0.148||-85.283|||||5.051|-13.757|-13.884|-1.313|7.2|7.2|119.233|102458.8667|-62.7137|6.34|5.2
usa_2_0147|AXGT|201912|33.421|27.812||2.926||37.217|30.688|6.529||5.047|-741.996||||-1.6934||||23.1214|||0||3.2923|1.988|0.347|0|||2|1.2201||13.0857|22.7917||-0.62|22.7917||22.7917|||-0.62|0|-0.1001||-65.026|||||5.409|-14.048|-14.039|-1.066|5.12|5.12|104.1845|213817.7667|-32.8205|3.68|3.93
usa_2_0147|AXGT|202003|85.43|80.752||2.333||32.122|32.043|0.079||61.558|-758.644||||-0.4594||||18.3931|||0||1.7783|1.707|4.412|0|||1|0.896||28.6759|30.8951|38|-0.47|39.5263||39.5263|||-0.47|-70.81|-0.6067||-72.628|||||5.133|-16.366|-16.648|-0.44|2.44|2.44|31.1152|358638.2333|-77.1898|3.65|3.41
usa_2_0147|AXGT|202006|61.197|55.482||1.738||12.455|12.384|0.071||58.581|-767.238||||-0.9468||||1.9724|||0||0.6189|1.717|2.97|0|||2|1.912||16.8272|43.2872||-0.2|40.9734||40.9734|||-0.2|-3.93|-0.8154||-53.165|||||4.64|-8.564|-8.594|-0.796|2.98|2.98|60.063|175219.8|-51.6432|2.98|3
usa_2_0147|AXGT|202009|||||||||||||||-2.3859||||3.5309|||0||1.1143||||||2|1.2024||14.248||||47.2497||||||||||||||||||4.62|4.62|151.3635|1050383.8|-40.5556|3.5|